Post-marketing Surveillance on Efficacy and Safety of 3% N-Acetylcysteine Ophthalmic Solution (PAPITEIN<sup>®</sup>) on Canine Corneal Diseases

DOI

Bibliographic Information

Other Title
  • 3％N-アセチルシステイン点眼液（パピテイン<sup>®</sup>）の犬角膜障害に対する有効性および安全性に関する調査

Description

Clinical experiences were surveyed regarding the safety and efficacy of PAPITEIN®, 3% N-Acetylcysteine ophthalmic solution for canine corneal diseases due to traumatic keratitis and corneal ulcer. Three hundred eighty-four dogs were subjected to a six-year safety survey, and 354 dogs were subjected to a six-year efficacy survey. Side effects such as photophobia or descemetocele were seen in two of the 384 dogs, (0.52%). The efficacy rate in the 354 dogs was 86.7%. Based on these results, it was confirmed that PAPITEIN® is effective, with few adverse side effects.

Journal

Keywords

Details 詳細情報について

  • CRID
    1390282680165740032
  • NII Article ID
    130004493402
  • DOI
    10.11252/dobutsurinshoigaku.20.53
  • ISSN
    18811574
    13446991
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top